An additional case–control study aimed at investigating the association between renin–angiotensin–aldosterone system blockers and COVID‐19 reported also on oral anticoagulant use (odds ratio, 1.16; 95% CI 1.04–1.30) [19]. This evidence concerns the gene REN and COVID-19.